Detection of bcr/abl mRNA in a case of chronic myelogenous leukemia in long-term remission: CML or sensitivity of detection?

Chronic myelogenous leukemia (CML) is a myelo-proliferative disorder which, after a chronic phase which lasts an average of 3 years, evolves into an acute disease which is resistant to chemotherapy. Nevertheless, a few studies have reported cases in which partial or complete hematologic, cytogenetic and/or molecular remission of the disease were observed either spontaneously or after non intensive chemotherapy, with or without medullar aplasia. Some of these patients later relapsed into a blast crisis. We report a case of CML with clinical and hematologic remission for 19 years after two cycles of busulphan not causing medullar aplasia, negative for the BCR/ABL gene by Southern blot but with the gene's mRNA detectable by hot start nested RT-PCR.

[1]  T. Miyazaki,et al.  Spontaneous remission in a patient with chronic myelogenous leukemia. , 1997, The New England journal of medicine.

[2]  M. Vickers.  Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data , 1996, British journal of haematology.

[3]  A. V. van Kessel,et al.  A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone , 1996, Annals of Hematology.

[4]  G. Martinelli,et al.  Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. , 1996, Blood.

[5]  G. Huez,et al.  Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.

[6]  Smith Ag,et al.  Re-emergence of Philadelphia chromosome positive clone in a patient with previous spontaneous remission of chronic myeloid leukemia. , 1995 .

[7]  D. Amikam,et al.  Molecular analysis of an asymptomatic Ph‐positive CML patient with 27 years of prolonged remission , 1994, American journal of hematology.

[8]  M. Ferrò,et al.  [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. , 1993, Medicina clínica (Ed. impresa).

[9]  C. Fegan,et al.  SPONTANEOUS REMISSION IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA , 1989, British Journal of Haematology.

[10]  A. Lawrence,et al.  PROLONGED SURVIVAL IN CHRONIC GRANULOCYTIC LEUKAEMIA ASSOCIATED WITH LOSS OF THE PHILADELPHIA CHROMOSOME , 1989, British journal of haematology.

[11]  A. Audebert,et al.  Spontaneous regression of cytogenetic and haematologic anomalies in Ph ‐positive chronic myelogenous leukaemia , 1986, British journal of haematology.

[12]  C. Singer,et al.  Twenty‐five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion , 1984, British journal of haematology.

[13]  J. Whang‐Peng,et al.  Philadelphia-chromosome-positive preleukaemic state. , 1972, Lancet.

[14]  C. Sawyers,et al.  New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. , 1997, Haematologica.

[15]  A. Bosi,et al.  Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation. , 1996, Haematologica.

[16]  A. Provan,et al.  Re-emergence of Philadelphia chromosome positive clone in a patient with previous spontaneous remission of chronic myeloid leukemia. , 1995, Leukemia.